MYDOCALM - is a centrally acting skeletal muscle relaxant used for the treatment of increased muscle tone associated with neurological diseases. It has been used since the 1960s. Tolperisone is indicated for use in the treatment of pathologically increased tone of the skeletal muscle caused by neurological diseases (damage of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis) and of spastic paralysis and other encephalopathies manifested with muscular dystonia.
- Pathologically increased tone of the skeletal muscle caused by neurological diseases
- Muscular dystonia.
- Cervical and lumbar syndromes.
- Arthrosis of the large joints.
- Obliterating atherosclerosis of the extremity vessels.
- Diabetic angiopathy.
- Thromboangiitis obliterans.
- Raynaud's syndrome.
GUARANTEE & EXPIRY DATE
100% original from Hungarian pharmaceutical company Gedeon Richter.
All packs are air tight sealed and expire up to 01.2024.
Тolperisone is a centrally acting muscle relaxant that acts at the reticular formation in the brain stem by blocking voltage-gated sodium and calcium channels. Tolperisone is absorbed nearly completely from the gut and reaches its peak blood plasma concentration after 1.5 hours. It is extensively metabolised in the liver and kidneys. The substance is excreted via the kidneys in two phases; the first with a half-life of two hours, and the second with a half-life of 12 hours.
MYDOCALM comes in the form of tablets: 150 mg per tablet, 30 tablets per pack.
Tolperisone hydrochloride - 150 mg.
Lactose, citric acid monohydrate, anhydrous colloidal silicon, stearin, talc, microcrystalline cellulose, corn starch, titanium dioxide (E171), dye (E129 or E172).
Colloidal silicon dioxide, titanium dioxide (E171-77891); lactose monohydrate, macrogol 6000, hypromellose.
Orally, after food, without chewing, with some water.
Adults and children older than 14 years - usually start with 50 mg 2-3 times a day, gradually increasing the dose to 150 mg 2-3 times a day.
Children from 3 to 6 years of age - daily dose of 5 mg per 1 kg of body weight; 7-14 years - 2-4 mg per 1 kg of body weight (divided in 3 doses throughout the day).
- Parkinson's disease.
- Hypersensitivity to ingredients of Mydocalm.
Muscle weakness, headache, arterial hypotension, nausea, vomiting discomfort in the abdomen.
With a decrease in dose, side effects usually disappear.
In rare cases, allergic reactions occur (skin itching, erythema, urticaria, angioedema, anaphylactic shock, bronchospasm).
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Mydocalm.